touchpodcast
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...
Bezoek zeker de website van de podcast en steun de maker: touchpodcast.podbean.com
Auteur
touchpodcast
Categorie
Website van de podcast
Nieuwste aflevering
17 nov. 2026
Waar luisteren?
Podcasts in de app Replaio Radio Binnenkort beschikbaarPodcasts komen binnenkort naar de app. Installeer nu en zie als eerste een compleet nieuwe kijk op podcasts
Afleveringen
Treatment selection after EGFR-TKI therapy: Matching biology to strategy 17.11.2026 40:44
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: MET-driven progression: Targeting the bypass In this module, medical oncologist Dr. Julia Rotow explores the biological rationale and emerging clinical evidence behind MET amplification and overexpression as drivers of resistance following EGFR-TKI therapy in non-small cell lung cancer (NSCLC). Together with molecular path...
Clinical decisions in motion: Case-based strategies for up-to-date care in HER2-positive GI cancers 17.11.2026 53:41
touchCASES for touchONCOLOGY Listen to four experts as they discuss four clinical cases illustrating optimal care for treatment-naive or previously treated patients with HER2-positive gastrointestinal cancers. They examine key decision points from biomarker testing and therapy selection to ongoing management, in patients with either biliary tract cancer or gastroesophageal adenocarcinoma. The expe...
touchMDT – Beyond tumor control: Long-term management, recurrence and survivorship in TGCT 10.11.2026 14:08
touchMDT for touchONCOLOGY Beyond tumor control: Long-term management, recurrence and survivorship in TGCT Listen to our expert faculty explore key aspects of longitudinal tenosynovial giant cell tumor (TGCT) care, with a focus on monitoring, long-term outcomes, and optimizing care through coordinated multidisciplinary follow-up. The multidisciplinary team Orthopedic oncologist—Dr. Wakenda T...
touchMDT – Beyond tumor control: Long-term multidisciplinary management of TGCT 10.11.2026 18:54
touchMDT for touchONCOLOGY Beyond tumor control: Long-term multidisciplinary management of TGCT Listen to our expert faculty explore the long-term multidisciplinary management of tenosynovial giant cell tumor (TGCT), including treatment decision-making, the CSF-1R inhibitor landscape, and regional care differences across the USA, Europe, and China. The multidisciplinary team Orthopedic oncol...
touchMDT – Recognizing TGCT earlier: Improving clinical recognition 10.11.2026 15:29
touchMDT for touchONCOLOGY Recognizing TGCT earlier: Improving clinical recognition Listen to our expert faculty explore key clinical features and imaging hallmarks of tenosynovial giant cell tumor (TGCT), focusing on clinical red flags, differential diagnoses, and timely referral pathways to specialist sarcoma multidisciplinary teams. The multidisciplinary team Orthopedic oncologist—Dr. Wak...
Presbyopia-correcting IOL decision-making: Answering the challenging clinical questions 29.10.2026 18:29
touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen as Dr. Karolinne Rocha shares her insights on the clinical, diagnostic, and patient-specific factors that shape presbyopia-correcting intraocular lens (PCIOL) selection. She also discusses how shared decision-making and counseling can align patient expectations with likely outcomes, including in patients with previous refractive surgery. The expert...
Minimizing risk and maximizing care in metastatic breast cancer: A deep dive into ADC safety 29.10.2026 32:40
touchEXPERT FOCUS for touchONCOLOGY Dr. Sara Tolaney, a leading breast medical oncologist, shares insights into the distinct toxicity profiles of antibody–drug conjugates (ADCs) approved for metastatic breast cancer (mBC). She explores practical approaches for monitoring, recognizing, and diagnosing ADC-related side effects, and discusses evidence-based strategies for managing treatment-related to...
From first-line to next-gen: Tailoring hormonal contraception to the individual patient 22.10.2026 34:07
touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of interviews with Dr. Sheila Mody who will provide her expert insights into oral and nonoral hormonal contraceptive options, guidance on correct use of transdermal patches and strategies to support shared decision-making in selection of hormonal contraceptives. The expert: Dr. Sheila Mody based in San Diego, CA, USA This touchPODCAST is...
Glycogen storage disease type Ia: From pathophysiology to multidisciplinary management 21.10.2026 38:04
touchEXPERT FOCUS for touchENDOCRINOLOGY and touchHEPATOLOGY Hear from our expert faculty as they share insights into the pathophysiology, treatment, and multidisciplinary management of glycogen storage disease type Ia (GSDIa). This series of short interviews explores the clinical manifestations of the disorder and highlights how day-to-day standard of care requires a coordinated, multidisciplinar...
Operationalizing the cardiac amyloidosis MDT 20.10.2026 16:34
Listen to our expert faculty discuss multidisciplinary care for cardiac amyloidosis, including referral pathways, coordinated treatment decisions and collaboration between specialist centers and local care teams. They also explore monitoring and follow-up for cardiac amyloidosis. The multidisciplinary team: Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria Hemat...
Integrating emerging AL therapies into real‑world MDT decisions 20.10.2026 15:22
Listen to our expert faculty discuss multidisciplinary treatment decisions for amyloid light-chain amyloidosis (AL), including cardiac and renal care, treatment tolerability and frailty. They also explore emerging fibril-directed therapies and their potential role alongside plasma-cell–directed treatment, informed by clinical evidence and local approval. The multidisciplinary team: Hematologist –...
Building a shared AL vs. ATTR diagnostic pathway 20.10.2026 15:26
Listen to our expert faculty explore a shared diagnostic pathway for cardiac amyloidosis, including clinical and imaging red flags, monoclonal-protein testing, and the role of biopsy and amyloid typing. They also explore multidisciplinary collaboration and when to prioritize ruling out amyloid light-chain amyloidosis (AL). The multidisciplinary team: Cardiologist – Dr. Christian Nitsche, Medical...
touchEXPERT FOCUS - Integrating EGFR-directed strategies into early-stage NSCLC care 16.10.2026
touchEXPERT FOCUS for touchONCOLOGY & touchRESPIRATORY Listen to Dr. James CH Yang discuss the integration of EGFR-directed strategies into early-stage NSCLC care, covering patient selection for perioperative and adjuvant systemic therapy, optimizing treatment duration and interpreting recurrence risk, and proactive management of treatment-related adverse events to support sustained, curative-...
Expert insights on optimizing early discharge and home-based diuresis in HF 09.10.2026 18:03
touchEXPERT FOCUS for touchCARDIO Listen to Dr. Anuradha Lala-Trindade discuss the burden of heart failure hospitalization, why inpatient intravenous diuresis remains the conventional approach to worsening heart failure, and how outpatient and home-based decongestion strategies, supported by appropriate patient selection, monitoring and follow-up, can help overcome barriers to discharge and suppor...
Stargardt disease and the role of vitamin A: Disease pathogenesis and the promise of oral therapies 01.10.2026 19:19
touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to an interview with Dr. Christine Kay on the role of vitamin A in the retina, how vitamin A processing is disrupted in Stargardt disease, and the mechanism of action, emerging clinical evidence, and key safety considerations for emerging oral therapies. The expert: Dr. Christine Kay, Vitreoretinal Associates, Gainesville, FL, USA This activity is fu...
Management of NF1-related PNs: Approaches for delivering state-of-the-art care 29.09.2026 35:26
touchIN CONVERSATION for touchNEUROLOGY and touchONCOLOGY Management of neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas in adults requires individualized decisions that account for symptoms, function, resectability and patient goals. Listen to NF1 experts Prof. Allan Belzberg, a neurosurgeon, and Dr. Angela Hirbe, an oncologist, as they discuss targeted therapy, adverse-effect mo...
Raising awareness of Lennox–Gastaut syndrome: Recognition, polypharmacy, and non-seizure symptoms 25.09.2026 56:16
touchPANEL DISCUSSION for touchNEUROLOGY Hear from three experts as they share practical insights into recognizing and diagnosing Lennox–Gastaut syndrome across the lifespan, navigating the complexities of polytherapy, and addressing the cognitive, behavioral, functional, and quality of life challenges that extend beyond seizure control. The experts: Dr. Elaine Wirrell —Mayo Clinic, Rochester, MN,...
touchMDT - Coordinated care and evolving therapies: Implications for future pathways 17.09.2026 14:09
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control. The multidisciplinary team Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada Prof. Dr. Falk Bechara - Ruhr Univ...
touchMDT - Perineal and genital disease: Medical–surgical decision-making 17.09.2026 13:42
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss the medical and surgical decision-making challenges in perineal and genital HS, including common diagnostic pitfalls, how to integrate medical and surgical treatment, and the unique role of urology in managing complex disease. The multidisciplinary team Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, On...
touchMDT - Women’s health and HS: Vulvar disease, hormones and pregnancy 17.09.2026 13:00
Dr. Melinda Gooderham and Dr. Jillian Kerry discuss the unique challenges of hidradenitis suppurativa in women, including vulvar disease, hormonal influences, pregnancy, and the importance of collaboration between dermatology and obstetrics and gynecology. The multidisciplinary team Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada Dr. Jillian Kerry - University of...
touchMDT - Early recognition and referral: Capturing the window of opportunity 17.09.2026 14:31
Dr. Melinda Gooderham and Prof. Dr. Falk Bechara discuss opportunities for earlier recognition and referral of hidradenitis suppurativa, including key clinical clues, referral pathways, and the impact of diagnostic delay. A patient perspective highlights the importance of timely diagnosis and coordinated care. The multidisciplinary team Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterbor...
Empowering choice in HIV care: Moving beyond daily pills to person‐centered ART strategies 17.09.2026 35:36
touchEXPERT FOCUS for touchINFECTIOUS DISEASES Listen to a series of short interviews with three leading experts discussing preference-sensitive care for people living with HIV. Faculty consider the evolving landscape of simplified ART options, including long-acting injectable regimens, and provide practical strategies to align treatment choices with individual goals and preferences. They also dis...
Recognizing MOGAD: Defining a distinct demyelinating disease 11.09.2026 17:08
touchEXPERT FOCUS for touchNEUROLOGY, touchIMMUNOLOGY, touchOPHTHALMOLOGY Dr. Eoin Flanagan shares his expert insights on myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and how to distinguish it from other demyelinating diseases like multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-positive NMOSD). As part of the int...
Systemic mastocytosis: Making the right decisions at the right time (video 3) 02.09.2026 16:34
touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary c...
Systemic mastocytosis: Making the right decisions at the right time (video 2) 02.09.2026 16:33
touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary c...
Vergelijkbare podcasts
Replaio is geen uitgever van podcasts; namen van shows, covers en audio zijn eigendom van hun makers en worden verspreid via openbare RSS-feeds